Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2012 (2012), Article ID 347417, 11 pages
http://dx.doi.org/10.1155/2012/347417
Research Article

rAAV Vectors as Safe and Efficient Tools for the Stable Delivery of Genes to Primary Human Chondrosarcoma Cells In Vitro and In Situ

1Center of Experimental Orthopaedics, Saarland University Medical Center, Saarland, 66421 Homburg, Germany
2Department of Orthopaedic Surgery, Saarland University Medical Center, Saarland, 66421 Homburg, Germany

Received 1 December 2011; Revised 17 February 2012; Accepted 17 February 2012

Academic Editor: Irene Andrulis

Copyright © 2012 Henning Madry et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. A. Chow, “Update on chondrosarcomas,” Current Opinion in Oncology, vol. 19, no. 4, pp. 371–376, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. L. B. Rozeman, P. C. W. Hogendoorn, and J. V. M. G. Bovée, “Diagnosis and prognosis of chondrosarcoma of bone,” Expert Review of Molecular Diagnostics, vol. 2, no. 5, pp. 461–472, 2002. View at Google Scholar · View at Scopus
  3. A. A. Sandberg, “Genetics of chondrosarcoma and related tumors,” Current Opinion in Oncology, vol. 16, no. 4, pp. 342–354, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. Terek, “Recent advances in the basic science of chondrosarcoma,” Orthopedic Clinics of North America, vol. 37, no. 1, pp. 9–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Aigner, “Towards a new understanding and classification of chondrogenic neoplasias of the skeleton—biochemistry and cell biology of chondrosarcoma and its variants,” Virchows Archiv, vol. 441, no. 3, pp. 219–230, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Aigner, S. Dertinger, D. Neureiter, and T. Kirchner, “De-differentiated chondrosarcoma is not a 'de-differentiated' chondrosarcoma,” Histopathology, vol. 33, no. 1, pp. 11–19, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Aigner, S. Dertinger, S. I. Vornehm, J. Dudhia, K. Von Der Mark, and T. Kirchner, “Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms,” American Journal of Pathology, vol. 150, no. 6, pp. 2133–2141, 1997. View at Google Scholar · View at Scopus
  8. T. Aigner, S. Müller, D. Neureiter, D. M. Illstrup, T. Kirchner, and J. Björnsson, “Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas,” Cancer, vol. 94, no. 8, pp. 2273–2281, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. H. J. Mankin, K. P. Cantley, L. Lippiello, A. L. Schiller, and C. J. Campbell, “The biology of human chondrosarcoma. I. Description of the cases, grading, and biochemical analyses,” Journal of Bone and Joint Surgery American volume, vol. 62, no. 2, pp. 160–176, 1980. View at Google Scholar
  10. J. V. M. G. Bovée, P. C. W. Hogendoorn, J. S. Wunder, and B. A. Alman, “Cartilage tumours and bone development: molecular pathology and possible therapeutic targets,” Nature Reviews Cancer, vol. 10, no. 7, pp. 481–488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Geryk-Hall and D. P. M. Hughes, “Critical signaling pathways in bone sarcoma: candidates for therapeutic interventions,” Current Oncology Reports, vol. 11, no. 6, pp. 446–453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. A. Guise, R. O'Keefe, R. L. Randall, and R. M. Terek, “Molecular biology and therapeutics in musculoskeletal oncology,” Journal of Bone and Joint Surgery. A, vol. 91, no. 3, pp. 724–732, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. D. J. Papachristou and A. G. Papavassiliou, “Osteosarcoma and chondrosarcoma: new signaling pathways as targets for novel therapeutic interventions,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 5, pp. 857–862, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Aigner, S. Frischholz, S. Dertinger, F. Beier, I. Girkontaité, and K. Von Der Mark, “Type x collagen expression and hypertrophic differentiation in chondrogenic neoplasias,” Histochemistry and Cell Biology, vol. 107, no. 6, pp. 435–440, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. M. M. Cajaiba, Jianhua Luo, M. A. Goodman, K. A. Fuhrer, and U. N. M. Rao, “Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas,” International Journal of Surgical Pathology, vol. 18, no. 5, pp. 319–323, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. G. J. Oakley, K. Fuhrer, and R. R. Seethala, “Brachyury, sox-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis,” Modern Pathology, vol. 21, no. 12, pp. 1461–1469, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. C. H. Evans, S. C. Ghivizzani, and P. D. Robbins, “Orthopedic gene therapy in 2008,” Molecular Therapy, vol. 17, no. 2, pp. 231–244, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Uchida, M. Seto, N. Hashimoto, and N. Araki, “Molecular diagnosis and gene therapy in musculoskeletal tumors,” Journal of Orthopaedic Science, vol. 5, no. 4, pp. 418–423, 2000. View at Google Scholar · View at Scopus
  19. E. David, P. Guihard, B. Brounais et al., “Direct anti-cancer effect of oncostatin m on chondrosarcoma,” International Journal of Cancer, vol. 128, no. 8, pp. 1822–1835, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Furumatsu, N. Yamaguchi, K. Nishida et al., “Endostatin inhibits adhesion of endothelial cells to collagen i via α2β1 integrin, a possible cause of prevention of chondrosarcoma growth,” Journal of Biochemistry, vol. 131, no. 4, pp. 619–626, 2002. View at Google Scholar · View at Scopus
  21. R. S. Herbst, S. G. Eckhardt, R. Kurzrock et al., “Phase i dose-escalation study of recombinant human apo2l/trail, a dual proapoptotic receptor agonist, in patients with advanced cancer,” Journal of Clinical Oncology, vol. 28, no. 17, pp. 2839–2846, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Ho, A. Stojanovski, H. Whetstone et al., “Gli2 and p53 cooperate to regulate igfbp-3- mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors,” Cancer Cell, vol. 16, no. 2, pp. 126–136, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Ikegami, H. Akiyama, A. Suzuki et al., “Sox9 sustains chondrocyte survival and hypertrophy in part through pik3ca-akt pathways,” Development, vol. 138, no. 8, pp. 1507–1519, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Jamil, S. Howie, and D. M. Salter, “Therapeutic molecular targets in human chondrosarcoma,” International Journal of Experimental Pathology, vol. 91, no. 5, pp. 387–393, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Jiang, C. M. Dutton, W. N. Qi et al., “Inhibition of mmp-1 expression by antisense rna decreases invasiveness of human chondrosarcoma,” Journal of Orthopaedic Research, vol. 21, no. 6, pp. 1063–1070, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Jiang, C. M. Dutton, W. N. Qi, J. A. Block, N. Garamszegi, and S. P. Scully, “Sirna mediated inhibition of mmp-1 reduces invasive potential of a human chondrosarcoma cell line,” Journal of Cellular Physiology, vol. 202, no. 3, pp. 723–730, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Kawashima, A. Ogose, T. Yoshizawa et al., “Expression of the coxsackievirus and adenovirus receptor in musculoskeletal tumors and mesenchymal tissues: efficacy of adenoviral gene therapy for osteosarcoma,” Cancer Science, vol. 94, no. 1, pp. 70–75, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Ketola, A. M. Määttä, T. Pasanen, K. Tulimäki, and J. Wahlfors, “Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy,” International Journal of Molecular Medicine, vol. 13, no. 5, pp. 705–710, 2004. View at Google Scholar · View at Scopus
  29. D. W. Kim, K. O. Kim, M. J. Shin et al., “Sirna-based targeting of antiapoptotic genes can reverse chemoresistance in p-glycoprotein expressing chondrosarcoma cells,” Molecular Cancer, vol. 8, article no. 28, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. D. W. Kim, S. W. Seo, S. K. Cho et al., “Targeting of cell survival genes using small interfering rnas (SIRNAS) enhances radiosensitivity of grade ii chrondrosarcoma cells,” Journal of Orthopaedic Research, vol. 25, no. 6, pp. 820–828, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Lechler, T. Renkawitz, V. Campean et al., “The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro,” BMC Cancer, vol. 11, article no. 120, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. W. Lee, Y. H. Kim, H. B. Park et al., “The c-terminal domain of focal adhesion kinase reduces the tumor cell invasiveness in chondrosarcoma cell lines,” Journal of Orthopaedic Research, vol. 21, no. 6, pp. 1071–1080, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Lin, R. McGough, B. Aswad, J. A. Block, and R. Terek, “Hypoxia induces hif-1α and vegf expression in chondrosarcoma cells and chondrocytes,” Journal of Orthopaedic Research, vol. 22, no. 6, pp. 1175–1181, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. H. H. Mehta, Q. Gao, C. Galet et al., “Igfbp-3 is a metastasis suppression gene in prostate cancer,” Cancer Research, vol. 71, no. 15, pp. 5154–5163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. A. V. Mollano, J. A. Martin, and J. A. Buckwalter, “Chondrocyte senescence and telomere regulation: implications in cartilage aging and cancer (a brief review),” the Iowa Orthopaedic Journal, vol. 22, pp. 1–7, 2002. View at Google Scholar · View at Scopus
  36. F. Moussavi-Harami, A. Mollano, J. A. Martin et al., “Intrinsic radiation resistance in human chondrosarcoma cells,” Biochemical and Biophysical Research Communications, vol. 346, no. 2, pp. 379–385, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Peng, A. Usas, A. Olshanski et al., “Vegf improves, whereas sflt1 inhibits, bmp2-induced bone formation and bone healing through modulation of angiogenesis,” Journal of Bone and Mineral Research, vol. 20, no. 11, pp. 2017–2027, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. J. A. Rudnicki and A. M. C. Brown, “Inhibition of chondrogenesis by wnt gene expression in vivo and in vitro,” Developmental Biology, vol. 185, no. 1, pp. 104–118, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Sakimura, K. Tanaka, S. Yamamoto et al., “The effects of histone deacetylase inhibitors on the induction of differentiation in chondrosarcoma cells,” Clinical Cancer Research, vol. 13, no. 1, pp. 275–282, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. M. Schrage, S. Lam, A. G. Jochemsen et al., “Central chondrosarcoma progression is associated with prb pathway alterations: cdk4 down-regulation and p16 overexpression inhibit cell growth in vitro,” Journal of Cellular and Molecular Medicine, vol. 13, no. 9 A, pp. 2843–2852, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Seto, H. Wakabayashi, T. Yamazaki, J. Sonoda, Y. Shinto, and A. Uchida, “Gene therapy of chondrosarcoma using retrovirus vectors encoding the herpes simplex virus thymidine kinase gene,” International Journal of Oncology, vol. 14, no. 6, pp. 1137–1141, 1999. View at Google Scholar · View at Scopus
  42. M. L. Tan, P. F. M. Choong, and C. R. Dass, “Anti-chondrosarcoma effects of pedf mediated via molecules important to apoptosis, cell cycling, adhesion and invasion,” Biochemical and Biophysical Research Communications, vol. 398, no. 4, pp. 613–618, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Q. Tang, T. Q. Yan, W. Guo et al., “(-)-epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human indian hedgehog pathway in human chondrosarcoma cells,” Journal of Cancer Research and Clinical Oncology, vol. 136, no. 8, pp. 1179–1185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. Z. Wang, J. Bryan, C. Franz, N. Havlioglu, and L. J. Sandell, “Type iib procollagen nh2-propeptide induces death of tumor cells via interaction with integrins αvβ3 and αvβ5,” Journal of Biological Chemistry, vol. 285, no. 27, pp. 20806–20817, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Yuan, C. M. Dutton, and S. P. Scully, “Rnai mediated mmp-1 silencing inhibits human chondrosarcoma invasion,” Journal of Orthopaedic Research, vol. 23, no. 6, pp. 1467–1474, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Zhang, R. D. Howell, D. T. Alfonso et al., “Ifi16 inhibits tumorigenicity and cell proliferation of bone and cartilage tumor cells,” Frontiers in Bioscience, vol. 12, pp. 4855–4863, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Orth, A. Weimer, G. Kaul, D. Kohn, M. Cucchiarini, and H. Madry, “Analysis of novel nonviral gene transfer systems for gene delivery to cells of the musculoskeletal system,” Molecular Biotechnology, vol. 38, no. 2, pp. 137–144, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. C. H. Evans, S. C. Ghivizzani, and P. D. Robbins, “Progress and prospects: genetic treatments for disorders of bones and joints,” Gene Therapy, vol. 16, no. 8, pp. 944–952, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. X. Xiao, J. Li, and R. J. Samulski, “Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector,” Journal of Virology, vol. 70, no. 11, pp. 8098–8108, 1996. View at Google Scholar · View at Scopus
  50. P. J. Mease, N. Wei, E. J. Fudman et al., “Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 study,” Journal of Rheumatology, vol. 37, no. 4, pp. 692–703, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Madry and S. B. Trippel, “Efficient lipid-mediated gene transfer to articular chondrocytes,” Gene Therapy, vol. 7, no. 4, pp. 286–291, 2000. View at Google Scholar · View at Scopus
  52. R. J. Samulski, L. S. Chang, and T. Shenk, “A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication,” Journal of Virology, vol. 61, no. 10, pp. 3096–3101, 1987. View at Google Scholar · View at Scopus
  53. R. J. Samulski, L. S. Chang, and T. Shenk, “Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression,” Journal of Virology, vol. 63, no. 9, pp. 3822–3828, 1989. View at Google Scholar · View at Scopus
  54. M. Cucchiarini, M. Ekici, S. Schetting, D. Kohn, and H. Madry, “Metabolic activities and chondrogenic differentiation of human mesenchymal stem cells following recombinant adeno-associated virus-mediated gene transfer and overexpression of fibroblast growth factor 2,” Tissue Engineering. Part A, vol. 17, no. 15-16, pp. 1921–1933, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Cucchiarini, H. Madry, C. Ma et al., “Improved tissue repair in articular cartilage defects in vivo by raav-mediated overexpression of human fibroblast growth factor 2,” Molecular Therapy, vol. 12, no. 2, pp. 229–238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Cucchiarini, X. L. Ren, G. Perides, and E. F. Terwilliger, “Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors,” Gene Therapy, vol. 10, no. 8, pp. 657–667, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Cucchiarini, S. Schetting, E. F. Terwilliger, D. Kohn, and H. Madry, “Raav-mediated overexpression of fgf-2 promotes cell proliferation, survival, and α-sma expression in human meniscal lesions,” Gene Therapy, vol. 16, no. 11, pp. 1363–1372, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Cucchiarini, E. F. Terwilliger, D. Kohn, and H. Madry, “Remodelling of human osteoarthritic cartilage by fgf-2, alone or combined with sox9 via raav gene transfer,” Journal of Cellular and Molecular Medicine, vol. 13, no. 8 B, pp. 2476–2488, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Cucchiarini, T. Thurn, A. Weimer, D. Kohn, E. F. Terwilliger, and H. Madry, “Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor sox9,” Arthritis and Rheumatism, vol. 56, no. 1, pp. 158–167, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Madry, M. Cucchiarini, G. Kaul, D. Kohn, E. F. Terwilliger, and S. B. Trippel, “Menisci are efficiently transduced by recombinant adeno-associated virus vectors in vitro and in vivo,” American Journal of Sports Medicine, vol. 32, no. 8, pp. 1860–1865, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Madry, M. Cucchiarini, E. F. Terwilliger, and S. B. Trippel, “Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage,” Human Gene Therapy, vol. 14, no. 4, pp. 393–402, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. K. R. Clark, X. Liu, J. P. Mcgrath, and P. R. Johnson, “Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses,” Human Gene Therapy, vol. 10, no. 6, pp. 1031–1039, 1999. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Goodman, X. Xiao, R. E. Donahue et al., “Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells,” Blood, vol. 84, no. 5, pp. 1492–1500, 1994. View at Google Scholar · View at Scopus
  64. R. J. Samulski, X. Zhu, X. Xiao et al., “Targeted integration of adeno-associated virus (aav) into human chromosome 19,” EMBO Journal, vol. 10, no. 12, pp. 3941–3950, 1991. View at Google Scholar · View at Scopus
  65. J. B. Vincourt, S. Etienne, J. Cottet et al., “C-propeptides of procollagens iα1 and ii that differentially accumulate in enchondromas versus chondrosarcomas regulate tumor cell survival and migration,” Cancer Research, vol. 70, no. 11, pp. 4739–4748, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. C. M. Schörle, F. Finger, A. Zien, J. A. Block, P. M. Gebhard, and T. Aigner, “Phenotypic characterization of chondrosarcoma-derived cell lines,” Cancer Letters, vol. 226, no. 2, pp. 143–154, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. M. O'Donovan, J. M. Russell, J. J. O'Leary, J. A. Gillan, M. P. Lawler, and E. F. Gaffney, “Abl expression, tumour grade, and apoptosis in chondrosarcoma,” Journal of Clinical Pathology - Molecular Pathology, vol. 52, no. 6, pp. 341–344, 1999. View at Google Scholar · View at Scopus
  68. J. Adriaansen, S. W. Tas, P. L. Klarenbeek et al., “Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy,” Annals of the Rheumatic Diseases, vol. 64, no. 12, pp. 1677–1684, 2005. View at Publisher · View at Google Scholar · View at Scopus
  69. M. C. Boissier, D. Lemeiter, C. Clavel et al., “Synoviocyte infection with adeno-associated virus (aav) is neutralized by human synovial fluid from arthritis patients and depends on aav serotype,” Human Gene Therapy, vol. 18, no. 6, pp. 525–535, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. K. G. Rendahl, S. E. Leff, G. R. Otten et al., “Regulation of gene expression in vivo following transduction by two separate raav vectors,” Nature Biotechnology, vol. 16, no. 8, pp. 757–761, 1998. View at Publisher · View at Google Scholar · View at Scopus